General Anesthesia Articles & Analysis
20 news found
The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. The reason for this difference is that the former is an anesthetic, while the latter is an analgesic—no sensation versus no pain. But pain elimination comes with a total lack of feeling in the lower body, due to ...
Having established close cooperative relations with many pharmaceutical companies, universities, and research institutions, Alfa Chemistry decided to enlarge its active pharmaceutical ingredient (API) supply continuously in the hope of providing a more diversified product portfolio for customers. Fairly recently, the company announced the launch of dexmedetomidine hydrochloride, another API ...
Small procedures on the body, like a skin biopsy, are great candidates for local anesthesia. An injection or topical cream may be used. If you’ve ever had an injection by a dentist, you’ve had a local anesthetic. Fast-acting, virtually pain-free and convenient, local anesthetics enable much of medicine to occur. Patients can remain awake and leave following their procedure. After ...
Who can benefit from an adjustable gastric band implant? Adults between the ages of 18 and 60 years with morbid obesity (BMI of > 40) or severe obesity (BMI of > 35) with at least one complication (diabetes, hypertension, sleep apnea syndrome, joint disorders) People who have already tried to lose weight without success despite receiving specialized medical care for several months ...
EvoEndo, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A financing round led by founding investor TLP Investment Partners LLC (TLP) and including the Sunshine Charitable Foundation and the Jill and Paul Meister family. Proceeds from the ...
ByEvoEndo
EvoEndo’s Single-Use Endoscopy System or the “EvoEndo System” eliminates the need for general anesthesia or conscious sedation during routine upper endoscopic procedures The EvoEndo System is being distributed by Micro-Tech Endoscopy USA with commercial sales slated to begin following completion of first clinical cases at several pediatric facilities EvoEndo, Inc. ...
ByEvoEndo
EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for unsedated endoscopy, today announced the signing of a distribution agreement with Micro-Tech Endoscopy USA, Inc. (“Micro-Tech”). The agreement, whereby Micro-Tech will distribute the EvoEndo® Single-Use Endoscopy System in the US, is expected to begin pending US FDA 510(k) clearance. ...
ByEvoEndo
EvoEndo Inc., (“EvoEndo” or “the Company”) a preclinical medical device company developing systems for unsedated Transnasal Endoscopy (TNE), announced it has secured $10.1M in equity financing. The funding round, which included a variety of family offices and early-stage life science investors, will be used to further EvoEndo’s innovative technology designed to help ...
ByEvoEndo
If you’ve ever had an awful sinus infection, you know how painful, and quite frankly, how much of a drag it is. But most of us don’t have Chronic Sinusitis, which consists of a sinus infection lasting longer than 3 months (despite treatment), according to the Mayo Clinic. That being said, 11.6% of the American population does, says the CDC. For years, if doctors couldn’t bring ...
Clinical investigators in the OverActive Bladder Stimulation System Study (OASIS) of the RENOVA iStim system, Drs. Becky McCrery and Emily Kean at Adult Pediatric Urology & Urogynecology in Omaha implanted the first U.S. patient in this international clinical study. The RENOVA iStim system is an investigational device designed to reduce urinary urge leakage and improve OAB symptoms. ...
BlueWind Medical announced today that enrollment has commenced at U. S. sites in the Pivotal Clinical Trial of the RENOVA iStim™ implantable tibial neuromodulation System (RENOVA) for the treatment of Overactive Bladder (OAB) following conditional Investigative Device Exemption (IDE) approval by the U.S. Food and Drug Administration (FDA). There are approximately 40 million adults in the ...
A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. The endolumenal ...
CORK MEDTECH STARTUP AventaMed has joined a consortium of big-name healthcare companies for collaborations ahead of a planned US launch. AventaMed has developed a device for inserting grommets into the eardrum, which prevents the build up of fluid. The consortium – called the National Evaluation System for Health Technology Coordinating Center (NESTcc) – connects regulators and the ...
AventaMed, a Cork-based medical device start-up which is set to revolutionise paediatric ear, nose and throat surgery has beaten 26 global organizations in a major medical device bid. The pioneering company will be one of 12 Real-World Evidence Test-Cases selected by The National Evaluation System for Health Technology Coordinating Center (NESTcc) to evaluate the use of real-world evidence (RWE) ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the Company’s Propofusor product containing 1% propofol in a single-use dispensing system. Uses of the Propofusor include the induction and maintenance of general anesthesia, sedation of mechanically ventilated ...
Mercury Biomed, a company developing a novel approach to managing core body temperature, was awarded a $1.5 million non-dilutive Phase II Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences (NIGMS). The award (2 R42 GM119871-02) will enable Mercury to continue along the path toward commercialization of its first device, WarmSmart, a ...
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science Officer Dr. Kristin Comella’s interview with Ben Pakulski — a world bodybuilding expert who last year received autologous stem cell therapy that successfully treated torn muscles. ...
Cork medtech firm seeks FDA clearance for Solo Tympanostomy Tube Device Cork Institute of Technology spin-out AventaMed has completed a €1.8 million funding round led by Halo Business Angel Network (HBAN). The investment will fund AventaMed through FDA (Food and Drug Administration) clearance and commercialisation of the Solo Tympanostomy Tube Device (Solo TTD) which enables the quick and ...
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces a €1.8 million investment in Cork-based medtech company, AventaMed. The investment – which includes €1.6 million angel funding, the largest single HBAN angel investment to date ...
Mercury Biomed, a company developing a novel approach to managing core body temperature, announces it has won a non-dilutive Phase I Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences (NIGMS) for $225,000. The award (R41GM119871) will enable Mercury to accelerate commercialization of its first device, a disruptive solution for warming ...